101 related articles for article (PubMed ID: 16867711)
1. Qualitative aspects of the degradation of mitomycins in alkaline solution.
Beijnen JH; den Hartigh J; Underberg WJ
J Pharm Biomed Anal; 1985; 3(1):71-9. PubMed ID: 16867711
[TBL] [Abstract][Full Text] [Related]
2. Aspects of the chemical stability of mitomycin and porfiromycin in acidic solution.
Underberg WJ; Lingeman H
J Pharm Sci; 1983 May; 72(5):549-53. PubMed ID: 6864504
[TBL] [Abstract][Full Text] [Related]
3. Development of new mitomycin C and porfiromycin analogues.
Iyengar BS; Lin HJ; Cheng L; Remers WA; Bradner WT
J Med Chem; 1981 Aug; 24(8):975-81. PubMed ID: 7328599
[TBL] [Abstract][Full Text] [Related]
4. MITOMYCINS AND PORFIROMYCIN: CHEMICAL MECHANISM OF ACTIVATION AND CROSS-LINKING OF DNA.
IYER VN; SZYBALSKI W
Science; 1964 Jul; 145(3627):55-8. PubMed ID: 14162693
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C and porfiromycin analogues with substituted ethylamines at position 7.
Iyengar BS; Sami SM; Remers WA; Bradner WT; Schurig JE
J Med Chem; 1983 Jan; 26(1):16-20. PubMed ID: 6827524
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
Fracasso PM; Sartorelli AC
Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
[TBL] [Abstract][Full Text] [Related]
8. Metabolites and DNA adduct formation from flavoenzyme-activated porfiromycin.
Pan SS; Iracki T
Mol Pharmacol; 1988 Aug; 34(2):223-8. PubMed ID: 3412325
[TBL] [Abstract][Full Text] [Related]
9. 7-N-(mercaptoalkyl)mitomycins: implications of cyclization for drug function.
Na Y; Wang S; Kohn H
J Am Chem Soc; 2002 May; 124(17):4666-77. PubMed ID: 11971715
[TBL] [Abstract][Full Text] [Related]
10. A comparison of mechanisms proposed for the conversion of mitomycins into mitosenes.
Iyengar BS; Remers WA
J Med Chem; 1985 Jul; 28(7):963-7. PubMed ID: 3925148
[TBL] [Abstract][Full Text] [Related]
11. pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin.
Siegel D; Beall H; Kasai M; Arai H; Gibson NW; Ross D
Mol Pharmacol; 1993 Dec; 44(6):1128-34. PubMed ID: 8264549
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography-thermospray mass spectrometry of DNA adducts formed with mitomycin C, porfiromycin and thiotepa.
Musser SM; Pan SS; Callery PS
J Chromatogr; 1989 Jul; 474(1):197-207. PubMed ID: 2504760
[TBL] [Abstract][Full Text] [Related]
13. PORFIROMYCIN.
DUVALL LR
Cancer Chemother Rep; 1963 Jul; 30():35-43. PubMed ID: 14051502
[No Abstract] [Full Text] [Related]
14. Decomposition of mitomycin and anthracycline cytostatics in cell culture media.
Beijnen JH; Van der Nat JM; Labadie RP; Underberg WJ
Anticancer Res; 1986; 6(1):39-43. PubMed ID: 3082277
[TBL] [Abstract][Full Text] [Related]
15. Determination of pKa values of some prototropic functions in mitomycin and porfiromycin.
Underberg WJ; Lingeman H
J Pharm Sci; 1983 May; 72(5):553-6. PubMed ID: 6306206
[No Abstract] [Full Text] [Related]
16. Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase.
Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):456-60. PubMed ID: 8552660
[TBL] [Abstract][Full Text] [Related]
17. Production of mitomycin C and porfiromycin by Streptomyces species.
Mandwal AK; Subramanian PM; Bhatia MC; Kapil RS; Popli SP; Vora VC
J Nat Prod; 1985; 48(2):334. PubMed ID: 3925088
[No Abstract] [Full Text] [Related]
18. Determination of the new anticancer agent KW 2149, 7-N-[2-[2-(gamma-L-glutamylamino)ethyl)dithio)ethyl]mitomycin C, an analogue of mitomycin C.
Pattyn G; van Oosterom AT; de Bruijn EA; Tjaden UR
J Chromatogr; 1991 Mar; 564(1):352-4. PubMed ID: 1860933
[TBL] [Abstract][Full Text] [Related]
19. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
Keyes SR; Rockwell S; Sartorelli AC
Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
[TBL] [Abstract][Full Text] [Related]
20. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
Hughes CS; Irvin CG; Rockwell S
Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
